Inspire Medical Systems, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Inspire Medical Systems, Inc. (INSP) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$16.23 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-03
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$3.90M, a 178.01% decline year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$12.32M.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $6.63M, a 51.44% decline year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $10.80M, a 36.88% increase year-over-year.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $6.12M, a 52.41% decline from fiscal 2024.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $12.87M, a 86.50% increase from fiscal 2023.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $6.90M, a 42.24% decline from fiscal 2022.
- Inspire Medical Systems, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $11.94M, a 69.20% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$16.23M 10-Q · filed 2026-08-03 | -$9.60M derived: sum of 3 quarters · filed 2026-08-03 | $1.21M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$12.32M 10-Q · filed 2026-05-04 | -$5.69M derived: sum of 2 quarters · filed 2026-05-04 | $5.11M derived: sum of 3 quarters · filed 2026-05-04 | $10.12M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $6.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $17.43M derived: sum of 2 quarters · filed 2026-02-13 | $22.44M derived: sum of 3 quarters · filed 2026-08-03 | $6.12M 10-K · filed 2026-02-13 |
| 2025-09-30 | $10.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $15.81M derived: sum of 2 quarters · filed 2026-08-03 | -$508.00K 10-Q · filed 2025-11-03 | $13.15M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $5.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$11.31M 10-Q · filed 2026-08-03 | $2.35M derived: sum of 3 quarters · filed 2026-08-03 | $10.24M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$16.32M 10-Q · filed 2026-05-04 | -$2.66M derived: sum of 2 quarters · filed 2026-05-04 | $5.23M derived: sum of 3 quarters · filed 2026-05-04 | $8.95M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $13.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $21.55M derived: sum of 2 quarters · filed 2026-02-13 | $25.26M derived: sum of 3 quarters · filed 2026-02-13 | $12.87M 10-K · filed 2026-02-13 |
| 2024-09-30 | $7.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $11.61M derived: sum of 2 quarters · filed 2025-11-03 | -$791.00K 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$8.68M 10-Q · filed 2025-08-04 | ||
| 2024-03-31 | -$12.40M 10-Q · filed 2025-05-05 | |||
| 2023-12-31 | $6.90M 10-K · filed 2026-02-13 | |||
| 2022-12-31 | $11.94M 10-K · filed 2025-02-10 | |||
| 2021-12-31 | $7.06M 10-K · filed 2024-02-09 | |||
| 2020-12-31 | $1.15M 10-K · filed 2023-02-10 | |||
| 2019-12-31 | $2.94M 10-K · filed 2022-02-15 | |||
| 2018-12-31 | $3.58M 10-K · filed 2021-02-24 | |||
| 2017-12-31 | $1.34M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |